ORIGINAL RESEARCH article
Front. Chem.
Sec. Theoretical and Computational Chemistry
Volume 13 - 2025 | doi: 10.3389/fchem.2025.1611972
This article is part of the Research TopicDynamics and Functional Exploration of Pharmacologically Active ProteinsView all 3 articles
Integrative Computational Approaches Identify Haptoglobin Inhibitors to Modulate Erythrocyte Sedimentation Rate in Trauma-Linked
Provisionally accepted- 1Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia
- 2Jamia Millia Islamia, New Delhi, National Capital Territory of Delhi, India
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Elevated levels of haptoglobin are commonly observed in conditions characterised by an increased erythrocyte sedimentation rate (ESR), which are acute-phase reactants. These conditions include infection, trauma, inflammation, hepatitis, amyloidosis, collagen diseases, lymphoma, leukaemia, as well as obstructive and biliary diseases. However, no significant drugs are currently available to manage these conditions, making therapeutic intervention crucial effectively. In this study, we performed an extensive screening of the DrugBank database against the human haptoglobin protein (PDB ID: 4X0L) using High-Throughput Virtual Screening (HTVS), Standard Precision (SP), and Extra Precision (XP) docking methods, followed by pose processing with Molecular Mechanics Generalised Born Surface Area (MM/GBSA) calculations. This led to the identification of five potential inhibitors: L-histidinol phosphate (DB03997), L-gluconic acid (DB04304), 4-bromo-3-(carboxymethoxy)-5-(4-hydroxyphenyl)thiophene-2-carboxylic acid (DB07197), 3-O-methylfructose (DB02438), and glutamine hydroxamate (DB02446), with docking scores ranging from -7.96 to -5.58 kcal/mol and MM/GBSA scores between -26.23 to -1.00 kcal/mol. The study also included Density Functional Theory (DFT) computations and pharmacokinetic profiling to assess these compounds' suitability further, revealing promising results. Additionally, we conducted molecular interaction fingerprint analysis, revealing key residues involved in interactions, including 10LYS (Basic), 8LEU (non-polar), 7ASP (Acidic), and 7THR (Polar), indicating a mixed interaction profile. A 5 ns WaterMap analysis was used to identify optimal hydration sites and interaction patterns. Moreover, a 100 ns molecular dynamics (MD) simulation using the TIP3P water model in the NPT ensemble confirmed the stability of the protein-ligand complexes, with acceptable deviations, fluctuations, and intermolecular interactions. MM/GBSA calculations on the simulation trajectories supported these findings by providing binding free energy and complex energy estimations for all protein-ligand complexes. Although these findings provide compelling computational evidence for haptoglobin inhibition, experimental studies must confirm its effectiveness before human use.
Keywords: Haptoglobin, molecular docking, Density Functional Theory, WaterMap, binding free energy
Received: 15 Apr 2025; Accepted: 23 May 2025.
Copyright: © 2025 Al Khzem and Ahmad. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Abdulaziz Al Khzem, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia
Shaban Ahmad, Jamia Millia Islamia, New Delhi, 110025, National Capital Territory of Delhi, India
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.